115563
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.6 Breast Cancer (Dove Med Press)
- 4.3 Clin Epidemiol
- 2.6 Cancer Manag Res
- 3.2 Infect Drug Resist
- 4.1 Clin Interv Aging
- 6.1 Drug Des Dev Ther
- 4.1 Int J Chronic Obstr
- 8.7 Int J Nanomed
- 2.5 Int J Women's Health
- 3.2 Neuropsych Dis Treat
- 2.4 OncoTargets Ther
- 2.6 Patient Prefer Adher
- 2.6 Ther Clin Risk Manag
- 3.1 J Pain Res
- 3.5 Diabet Metab Synd Ob
- 4.5 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 2.4 Pharmgenomics Pers Med
- 2.6 Risk Manag Healthc Policy
- 4.6 J Inflamm Res
- 2.3 Int J Gen Med
- 3.9 J Hepatocell Carcinoma
- 3.3 J Asthma Allergy
- 2.5 Clin Cosmet Investig Dermatol
- 3.0 J Multidiscip Healthc
已发表论文
维生素 D 受体在癌症中的作用：生物学功能、机制见解及临床相关性
Authors Liang M, Yin S, Dai Y, Xu F, Chang B , Volarević S , Li X, Wu D, Li Z, Wang T
Received 29 September 2025
Accepted for publication 16 December 2025
Published 8 January 2026 Volume 2026:18 571200
DOI https://doi.org/10.2147/CMAR.S571200
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Professor Seema Singh
Ming Liang,1,* Shengjie Yin,2,* Yisheng Dai,3,* Fan Xu,4 Bowen Chang,4 Siniša Volarević,5 Xiaobo Li,4 Di Wu,6 Zhiwei Li,3 Tianzhen Wang4
1Department of Infection, Second Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China; 2Department of Medical Oncology, Chifeng Municipal Hospital, Chifeng, People’s Republic of China; 3Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, People’s Republic of China; 4Department of Pathology, Harbin Medical University, Harbin, People’s Republic of China; 5Department of Molecular Medicine and Biotechnology, University of Rijeka Faculty of Medicine, Rijeka, Croatia; 6Department of Obstetrics and Gynecology, First Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zhiwei Li, Email lizhiwei@hrbmu.edu.cn Tianzhen Wang, Email wtzpath@163.com
Abstract: Vitamin D (VD) has been the focus of extensive clinical research, yet conclusions regarding its biological roles remain inconsistent. VD exerts its functions through the vitamin D receptor (VDR), a nuclear transcription factor that regulates the expression of VD3-responsive target genes. Notably, divergent findings across studies have been reported regarding VDR expression patterns and functional roles, underscoring the complexity of VDR in cancer biology. Whether this complexity interferes with VD’s biological activity-thereby contributing to the variable impacts of VD3 on cancer prevention and treatment-remains unclear. This review systematically addresses: (1) the association between VDR expression (assessed by immunohistochemistry) and cancer prognosis; (2) the roles and mechanisms of VDR in cancer; (3) the multi-level regulatory networks governing VDR expression and activity; and (4) the translational implications of VDR in cancer therapy. Elucidating the precise roles and mechanisms of VDR is critical for optimizing cancer treatment strategies and resolving conflicting clinical evidence.
Keywords: vitamin D receptor, cancer, prognosis, function and mechanism, therapy
1Department of Infection, Second Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China; 2Department of Medical Oncology, Chifeng Municipal Hospital, Chifeng, People’s Republic of China; 3Department of Gastrointestinal Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, People’s Republic of China; 4Department of Pathology, Harbin Medical University, Harbin, People’s Republic of China; 5Department of Molecular Medicine and Biotechnology, University of Rijeka Faculty of Medicine, Rijeka, Croatia; 6Department of Obstetrics and Gynecology, First Affiliated Hospital of Harbin Medical University, Harbin, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Zhiwei Li, Email lizhiwei@hrbmu.edu.cn Tianzhen Wang, Email wtzpath@163.com
Abstract: Vitamin D (VD) has been the focus of extensive clinical research, yet conclusions regarding its biological roles remain inconsistent. VD exerts its functions through the vitamin D receptor (VDR), a nuclear transcription factor that regulates the expression of VD3-responsive target genes. Notably, divergent findings across studies have been reported regarding VDR expression patterns and functional roles, underscoring the complexity of VDR in cancer biology. Whether this complexity interferes with VD’s biological activity-thereby contributing to the variable impacts of VD3 on cancer prevention and treatment-remains unclear. This review systematically addresses: (1) the association between VDR expression (assessed by immunohistochemistry) and cancer prognosis; (2) the roles and mechanisms of VDR in cancer; (3) the multi-level regulatory networks governing VDR expression and activity; and (4) the translational implications of VDR in cancer therapy. Elucidating the precise roles and mechanisms of VDR is critical for optimizing cancer treatment strategies and resolving conflicting clinical evidence.
Keywords: vitamin D receptor, cancer, prognosis, function and mechanism, therapy